MedX Health Gestione

Gestione criteri di controllo 3/4

MedX Health Il CEO è Stephen Lockyer, nominato in May2023, ha un mandato di 1.5 anni. possiede direttamente 0.04% delle azioni della società, per un valore di CA$ 6.44K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.4 anni e 6.5 anni.

Informazioni chiave

Stephen Lockyer

Amministratore delegato

CA$112.1k

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	1.5yrs
Proprietà del CEO	0.04%
Durata media del management	3.4yrs
Durata media del Consiglio di amministrazione	6.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Stephen Lockyer

1.5yrs

Mandato

CA$112,123

Compensazione

Mr. Stephen Lockyer serves as Director of MedX Health Corp since April 12, 2023 and serves as its Chief Executive Officer since May 09, 2023. He co founded Cornwallis Financial Corporation and serves as it...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Stephen Lockyer	CEO & Director	1.5yrs	CA$112.12k	0.040% CA$ 6.4k
Christopher Freeman	Corporate Secretary & Acting CFO	2.6yrs	CA$6.73k	Nessun dato
Michael Druhan	President of Dermatological Services & Products	4.2yrs	CA$284.85k	Nessun dato
Scott Naughton	Managing Director of US Operations	7.9yrs	Nessun dato	Nessun dato

3.4yrs

Durata media

Gestione esperta: Il team dirigenziale di MDX è considerato esperto (durata media dell'incarico 3.4 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Stephen Lockyer	CEO & Director	1.6yrs	CA$112.12k	0.040% CA$ 6.4k
David Henniger	Independent Vice Chairman	23yrs	Nessun dato	1.31% CA$ 213.2k
Kenneth McKay	Independent Chairman	23yrs	Nessun dato	0.32% CA$ 52.1k
Daniel Siegel	Member of Medical Advisory Board	6.5yrs	Nessun dato	Nessun dato
Dennis Reich	Member of Medical Advisory Board	7.8yrs	Nessun dato	Nessun dato
Trevor Champagne	Chairman of Medical Advisory Board	6.3yrs	Nessun dato	Nessun dato
Joe Walls	Member of Medical Advisory Board	no data	Nessun dato	Nessun dato
Per Hall	Member of Medical Advisory Board	no data	Nessun dato	Nessun dato
Edmund Ho	Independent Director	1.6yrs	Nessun dato	4.53% CA$ 734.7k

6.5yrs

Durata media

73yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di MDX sono considerati esperti (durata media dell'incarico 6.5 anni).

MedX Health Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

MedX Health Corp, Annual General Meeting, Dec 10, 2024

CEO & Director exercised options to buy CA$1.3m worth of stock.

MedX Health Corp Announces Resignation of Naman Damaghlatrous as Director

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

New major risk - Market cap size

MedX Health Corp, Annual General Meeting, Dec 10, 2024

Second quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.007 loss in 2Q 2023)

New major risk - Market cap size

MedX Health Corp announced that it has received CAD 1.05 million in funding

First quarter 2024 earnings released: CA$0.004 loss per share (vs CA$0.007 loss in 1Q 2023)

Full year 2023 earnings released: CA$0.023 loss per share (vs CA$0.028 loss in FY 2022)

MedX Health Corp announced that it expects to receive CAD 2 million in funding

New major risk - Share price stability

Third quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.006 loss in 3Q 2022)

CEO & Director exercised options to buy CA$1.3m worth of stock.

MedX Health Corp announced that it has received CAD 1.02 million in funding

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding

New minor risk - Shareholder dilution

Second quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 2Q 2022)

New major risk - Share price stability

First quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 1Q 2022)

MedX Health Corp Announces Resignation of Naman Damaghlatrous as Director

Full year 2022 earnings released: CA$0.028 loss per share (vs CA$0.03 loss in FY 2021)

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding from Forest Lane Holdings Limited

Third quarter 2022 earnings released: CA$0.006 loss per share (vs CA$0.009 loss in 3Q 2021)

MedX Health Corp announced that it expects to receive CAD 1.5 million in funding from Forest Lane Holdings Limited

Second quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.007 loss in 2Q 2021)

MedX Health Corp announced that it expects to receive CAD 4 million in funding

Full year 2021 earnings released: CA$0.03 loss per share (vs CA$0.019 loss in FY 2020)

MedX Health Corp announced that it expects to receive CAD 4 million in funding

Third quarter 2021 earnings: EPS in line with analyst expectations despite revenue beat

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Chairman of the Board Robert von der Porten has left the company

Second quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.004 loss in 2Q 2020)

COO & MD of Light Therapy Products recently sold CA$53k worth of stock

First quarter 2021 earnings released: CA$0.006 loss per share (vs CA$0.005 loss in 1Q 2020)

MedX Health Corp announced that it expects to receive CAD 2.5 million in funding

Full year 2020 earnings released: CA$0.019 loss per share (vs CA$0.023 loss in FY 2019)

MedX Health Corp. Announces Retirement of Board Members

EMPOWER CLINICS INC. and MedX Health Corporation Announce Memorandum of Understanding to Pilot MedX's Leading-Edge DermSecure Screening Platform At Two Select Empower Clinics Locations in Ontario

MedX Health Corp. Announces the Appointment of Paul Karam as Sales and Marketing Director for Europe, Middle East, Africa (EMEA)

New 90-day high: CA$0.24

MedX Health Corp announced that it expects to receive CAD 4 million in funding

MedX Health Corporation Appoints Trevor Champagne as Chair Medical Advisory Board

Medx Health Corp. Announces the Rollout of DermSecure in the Netherlands

Third quarter 2020 earnings released: CA$0.006 loss per share

MedX Health Corp Announces Board Changes

Medx Health Corp. Appoints Anthony Milonas and Wayne Cockburn as Directors

First half earnings released

MedX Health Corp. Announces Management Appointments

MedX Health Corp announced that it expects to receive CAD 2 million in funding

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Membri del Consiglio di amministrazione

Durata media

Età media